News

Surrogacy goes more mainstream

By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

U.S. Federal

Eugenics and the Modern Synthesis, Part I

By Jessica Riskin, Los Ángeles Review of Books | 03.23.2026

This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...

Civil Society

Surrogacy laws are all over the map

By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing...

Policies

Project Eugenics: The Rollback of Disability Rights

By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026

"MC0_8230" via Wikimedia Commons licensed under CC by 2.0 

This report documents a deliberate assault on disabled people in...

U.S. States

Bill to expand market in women’s egg donations would undermine safeguards

By Deborah Ortiz, Sacramento Bee | 08.04.2016
Untitled Document

Assembly Bill 2531 is working its way through the Legislature and would expand the market in women’s egg...

Fact Sheets

What Ever Happened to Cloning?

By Kimberly Leonard, US News & World Report | 08.04.2016
Untitled Document

A recent study revealed that sheep created from the same biological matter used to make Dolly, the first...

Public Opinion

NIH Plans To Lift Ban On Research Funds For Part-Human, Part-Animal Embryos

By Rob Stein, NPR | 08.04.2016
Untitled Document

The federal government announced plans Thursday to lift a moratorium on funding of certain controversial experiments that use...

U.S. Federal

In crisis-hit Venezuela young women seek sterilisation

By Alexandra Ulmer, Reuters | 08.03.2016
Untitled Document

This article is accompanied by 14 photographs by Carlos Garcia Rawlins, see the original article on Reuters...

Biopolitics

Why gene-therapy drugs are so expensive

By N.L., The Economist | 08.03.2016
Untitled Document

On August 3rd the British pharmaceutical company GSK said that it would charge €594,000 ($665,000) for a gene-therapy...

Bioethics

Peter Thiel Is Very, Very Interested in Young People's Blood

By Jeff Bercovici, Inc. | 08.01.2016
Untitled Document

More than anything, Peter Thiel, the billionaire technology investor and Donald Trump supporter, wants to find a...

A "Post-Human" Future?

23andMe data points to genes affecting depression risk

By Malcolm Ritter, Associated Press | 08.01.2016
Untitled Document

NEW YORK — In a key advance for the study of depression, a comprehensive scan of human DNA...

Genomics

<i>NY Times</i>: Fresh and Major Attention to Immunotherapy and Cancer

By David Jensen, California Stem Cell Report | 07.31.2016
Untitled Document The New York Times this weekend unveiled a dramatic, special report on immunotherapy to treat cancer, a field...
Genomics